Recent Advances in Toll Like Receptor-Targeting Glycoconjugate Vaccines
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recent Advances in Toll Like Receptor-Targeting Glycoconjugate Vaccines
Authors
Keywords
-
Journal
MOLECULES
Volume 23, Issue 7, Pages 1583
Publisher
MDPI AG
Online
2018-06-29
DOI
10.3390/molecules23071583
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Augmenting Vaccine Immunogenicity through the Use of Natural Human Anti-rhamnose Antibodies
- (2018) Md Kamal Hossain et al. ACS Chemical Biology
- Toll-like Receptor Agonist Conjugation: A Chemical Perspective
- (2018) Bob J. Ignacio et al. BIOCONJUGATE CHEMISTRY
- TLR10 suppresses the activation and differentiation of monocytes with effects on DC-mediated adaptive immune responses
- (2017) Nicholas J. Hess et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Development of Clickable Monophosphoryl Lipid A Derivatives toward Semisynthetic Conjugates with Tumor-Associated Carbohydrate Antigens
- (2017) Marcello Ziaco et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and Immunological Comparison of Differently Linked Lipoarabinomannan Oligosaccharide–Monophosphoryl Lipid A Conjugates as Antituberculosis Vaccines
- (2017) Lizhen Wang et al. JOURNAL OF ORGANIC CHEMISTRY
- Ni(II) interaction with a peptide model of the human TLR4 ectodomain
- (2017) Massimiliano Peana et al. JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY
- Progress in the synthesis and biological evaluation of lipid A and its derivatives
- (2017) Jian Gao et al. MEDICINAL RESEARCH REVIEWS
- The Novel Toll-Like Receptor 2 Agonist SUP3 Enhances Antigen Presentation and T Cell Activation by Dendritic Cells
- (2017) Xueheng Guo et al. Frontiers in Immunology
- Synthesis and Evaluation of GM2-Monophosphoryl Lipid A Conjugate as a Fully Synthetic Self-Adjuvant Cancer Vaccine
- (2017) Zhifang Zhou et al. Scientific Reports
- Synthetic MUC1 Antitumor Vaccine Candidates with Varied Glycosylation Pattern BearingR/S-configured Pam3CysSerLys4
- (2016) Lei Shi et al. CHEMBIOCHEM
- A Semisynthetic Approach to New Immunoadjuvant Candidates: Site-Selective Chemical Manipulation of Escherichia coli Monophosphoryl Lipid A
- (2016) Daniele D'Alonzo et al. CHEMISTRY-A EUROPEAN JOURNAL
- Fully Synthetic Self-Adjuvanting α-2,9-Oligosialic Acid Based Conjugate Vaccines against Group C Meningitis
- (2016) Guochao Liao et al. ACS Central Science
- Synthesis of a TLR4 Agonist-Carbohydrate Antigen Conjugate As A Self-Adjuvanting Cancer Vaccine
- (2016) Jordan D. Lewicky et al. ChemistrySelect
- Development of Globo-H Cancer Vaccine
- (2015) Samuel J. Danishefsky et al. ACCOUNTS OF CHEMICAL RESEARCH
- Protein Glycosylation in Cancer
- (2015) Sean R. Stowell et al. Annual Review of Pathology-Mechanisms of Disease
- Guiding Principles in the Design of Molecular Bioconjugates for Vaccine Applications
- (2015) Haipeng Liu et al. BIOCONJUGATE CHEMISTRY
- Synthesis of a Liposomal MUC1 Glycopeptide-Based Immunotherapeutic and Evaluation of the Effect of l-Rhamnose Targeting on Cellular Immune Responses
- (2015) Partha Karmakar et al. BIOCONJUGATE CHEMISTRY
- Design, synthesis and immunological evaluation of 1,2,3-triazole-tethered carbohydrate–Pam 3 Cys conjugates as TLR2 agonists
- (2015) Naresh Nalla et al. BIOORGANIC & MEDICINAL CHEMISTRY
- A fully synthetic self-adjuvanting globo H-Based vaccine elicited strong T cell-mediated antitumor immunity
- (2015) Zhifang Zhou et al. Chemical Science
- Immunological Features and Clinical Benefits of Conjugate Vaccines against Bacteria
- (2015) Paolo Durando et al. Journal of Immunology Research
- Synthetic self-adjuvanting glycopeptide cancer vaccines
- (2015) David M. McDonald et al. Frontiers in Chemistry
- Synthetic Multivalent Glycopeptide-Lipopeptide Antitumor Vaccines: Impact of the Cluster Effect on the Killing of Tumor Cells
- (2014) Hui Cai et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Immune and Anticancer Responses Elicited by Fully Synthetic Aberrantly Glycosylated MUC1 Tripartite Vaccines Modified by a TLR2 or TLR9 Agonist
- (2014) Abu-Baker M. Abdel-Aal et al. CHEMBIOCHEM
- Synthesis and immunological evaluation of self-adjuvanting MUC1-macrophage activating lipopeptide 2 conjugate vaccine candidates
- (2014) David M. McDonald et al. CHEMICAL COMMUNICATIONS
- N-Tetradecylcarbamyl Lipopeptides as Novel Agonists for Toll-like Receptor 2
- (2014) Marian M. J. H. P. Willems et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and evaluation of monophosphoryl lipid A derivatives as fully synthetic self-adjuvanting glycoconjugate cancer vaccine carriers
- (2014) Zhifang Zhou et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- CpG-Loaded Multifunctional Cationic Nanohydrogel Particles as Self-Adjuvanting Glycopeptide Antitumor Vaccines
- (2014) Sebastian Hartmann et al. Advanced Healthcare Materials
- Synthesis and Immunological Evaluation of a MUC1 Glycopeptide Incorporated into l-Rhamnose Displaying Liposomes
- (2013) Sourav Sarkar et al. BIOCONJUGATE CHEMISTRY
- Protein carriers of conjugate vaccines: Characteristics, development and clinical trials
- (2013) Michael E Pichichero Human Vaccines & Immunotherapeutics
- Mechanisms of Action of Adjuvants
- (2013) Sunita Awate et al. Frontiers in Immunology
- Synthesis and Immunological Evaluation of Self-Assembling and Self-Adjuvanting Tricomponent Glycopeptide Cancer-Vaccine Candidates
- (2012) Brendan L. Wilkinson et al. CHEMISTRY-A EUROPEAN JOURNAL
- Novel Toll-like Receptor 2 Ligands for Targeted Pancreatic Cancer Imaging and Immunotherapy
- (2012) Amanda Shanks Huynh et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and immunostimulatory activity of diethanolamine-containing lipid A mimics
- (2012) Jordan D. Lewicky et al. RSC Advances
- Carbohydrate-Monophosphoryl Lipid A Conjugates Are Fully Synthetic Self-Adjuvanting Cancer Vaccines Eliciting Robust Immune Responses in the Mouse
- (2011) Qianli Wang et al. ACS Chemical Biology
- Self-Adjuvanting Multicomponent Cancer Vaccine Candidates Combining Per-Glycosylated MUC1 Glycopeptides and the Toll-like Receptor 2 Agonist Pam3CysSer
- (2011) Brendan L. Wilkinson et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Towards a Fully Synthetic MUC1-Based Anticancer Vaccine: Efficient Conjugation of Glycopeptides with Mono-, Di-, and Tetravalent Lipopeptides Using Click Chemistry
- (2011) Hui Cai et al. CHEMISTRY-A EUROPEAN JOURNAL
- Toll-like Receptor 4 (TLR4) Is Essential for Hsp70-like Protein 1 (HSP70L1) to Activate Dendritic Cells and Induce Th1 Response
- (2011) Hongliang Fang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design
- (2011) Fikri Y Avci et al. NATURE MEDICINE
- Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine
- (2011) V. Lakshminarayanan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural requirement for the agonist activity of the TLR2 ligand Pam2Cys
- (2010) Weiguang Zeng et al. AMINO ACIDS
- Fully Synthetic Vaccines Consisting of Tumor-Associated MUC1 Glycopeptides and a Lipopeptide Ligand of the Toll-like Receptor 2
- (2010) Anton Kaiser et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Synthesis of MUC1–lipopeptide chimeras
- (2010) Brendan L. Wilkinson et al. CHEMICAL COMMUNICATIONS
- Vaccine Adjuvants: Putting Innate Immunity to Work
- (2010) Robert L. Coffman et al. IMMUNITY
- Structure−Activity Relationships in Toll-like Receptor-2 Agonistic Diacylthioglycerol Lipopeptides
- (2010) Wenyan Wu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Carbohydrate vaccines: developing sweet solutions to sticky situations?
- (2010) Rena D. Astronomo et al. NATURE REVIEWS DRUG DISCOVERY
- Linear and Branched Glyco-Lipopeptide Vaccines Follow Distinct Cross-Presentation Pathways and Generate Different Magnitudes of Antitumor Immunity
- (2010) Olivier Renaudet et al. PLoS One
- Structure–activity relationship of lipopeptide Group A streptococcus (GAS) vaccine candidates on toll-like receptor 2
- (2010) Mehfuz Zaman et al. VACCINE
- How Bacterial Carbohydrates Influence the Adaptive Immune System
- (2009) Fikri Y. Avci et al. Annual Review of Immunology
- Evidence that opioids may have toll-like receptor 4 and MD-2 effects
- (2009) Mark R. Hutchinson et al. BRAIN BEHAVIOR AND IMMUNITY
- Immunotherapy for cancer: synthetic carbohydrate-based vaccines
- (2009) Therese Buskas et al. CHEMICAL COMMUNICATIONS
- Synthesis of a monophosphoryl lipid A derivative and its conjugation to a modified form of a tumor-associated carbohydrate antigen GM3
- (2009) Qianli Wang et al. CHEMICAL COMMUNICATIONS
- Synthesis of a Monophosphoryl Derivative ofEscherichia coliLipid A and Its Efficient Coupling to a Tumor-Associated Carbohydrate Antigen
- (2009) Shouchu Tang et al. CHEMISTRY-A EUROPEAN JOURNAL
- The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex
- (2009) Beom Seok Park et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now